Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities

Pavel Pugach, Neelanjana Ray, Per Johan Klasse, Thomas J. Ketas, Elizabeth Michael, Robert W. Doms, Benhur Lee, John P. Moore

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

HIV-1 variants resistant to small molecule CCR5 inhibitors such as vicriviroc (VVC) have modified Env complexes that can use both the inhibitor-bound and -free forms of the CCR5 co-receptor to enter target cells. However, entry via the inhibitor-CCR5 complex is inefficient in some, but not all, cell types, particularly cell lines engineered to express CCR5. We investigated the effect of increasing CCR5 expression, and hence the density of the inhibitor-CCR5 complex when a saturating inhibitor (VVC) concentration was present, by using 293-Affinofile cells, in which CCR5 expression is up-regulated by the transcriptional activator, ponasterone. When CCR5 expression was low, the resistant virus entered the target cells to a lesser extent when VVC was present than absent. However, at a higher CCR5 level, there was much less entry inhibition at a constant, saturating VVC concentration. We conclude that the relative decrease in entry of a VVC-resistant virus in some cell types results from its less efficient use of the VVC-CCR5 complex, and that increasing the CCR5 expression level can compensate for this inefficiency.

Original languageEnglish
Pages (from-to)296-302
Number of pages7
JournalVirology
Volume387
Issue number2
DOIs
StatePublished - 10 May 2009
Externally publishedYes

Keywords

  • CCR5
  • CCR5 antagonists
  • Escape mutants
  • HIV inhibitors

Fingerprint

Dive into the research topics of 'Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities'. Together they form a unique fingerprint.

Cite this